Professor, Neuro-Oncology. Clinician, scientist, husband, dad, swimmer.Tweets are my own.
San Francisco, CA
Joined December 2015
- Tweets181
- Following99
- Followers1.3K
- Likes281
John de Groot, MD retweeted
Our newly activated trial is specifically designed for patients with oligodendroglioma (CIC mutated) and NF1-associated gliomas clinicaltrials.gov/ct2/show/…. Excited to announce this unique trial and accrue patients! #endcancer, @MDAndersonNews
John de Groot, MD retweeted
Really wonderful @NBTStweets walk today. Nice to see so many clinicians, scientists, patients, and caregivers together! @NeurosurgUCSF @UCSFCancer @UCSF
Team @NeurosurgUCSF representation at @NBTStweets walk @sfzoo!! Such an inspiring event celebrating and honoring our patients.
John de Groot, MD retweeted
Exciting news from #ASCO23. The phase III INDIGO trial demonstrated very promising results. If approved, the drug vorasidenib could become a new standard of care for patients with grade 2 IDH mutant oligodendrogliomas and astrocytomas.
INDIGO results just presented at #ASCO23: Vorasidenib significantly reduced the risk of disease progression or death compared with placebo in patients with IDH-mutant grade 2 glioma: fal.cn/3yO0q #ASCODailyNews @MSKCancerCenter #hncsm
John de Groot, MD retweeted
@WilliamCChen1 presenting his award-winning research on a biomarker that predicts #meningioma radiation response at #ASCO2023. Photo credit to @J_deGrootMD @JennieWTaylor and Susan Chang! @NeurosurgUCSF @UCSFCancer @UCSF
John de Groot, MD retweeted
GBM AGILE leadership gathering at #ASCO2023
Coming up on 4 years since the study opened to enrollment, we have exciting plans to maximize learning from every patient. Thank you trial leadership for your commitment to accelerating treatment discovery for patients with #glioblastoma
#FasterTogether
@TCloughesy @xelamb @J_deGrootMD @gliomadoc @ben_ellingson @MKhasraw @delaFuenteNOnc @NicholasBlondin @NBTSCSO @VPuduvalli @BerryConsultant + more
John de Groot, MD retweeted
Go @GCAResearch! So glad @NBTStweets @NBTSCSO, John Higgins, Managing Director of the Brain Tumor Investment Fund, and NBTS' volunteers will be part of this way to raise awareness during #GrayMay
.@GCAResearch and #GBMAGILE partners are ringing the @NasdaqExchange closing bell today in honor of National Brain Tumor Awareness Month! 🧠🙌🔔#GoGrayinMay
businesswire.com/news/home/2…
John de Groot, MD retweeted
The Kintara team was honored to ring the @NASDAQ #ClosingBell today alongside @GCAResearch and @NBTStweets in commemoration of National #BrainTumor Awareness Month. #GoGrayinMay
Learn more about our work: bit.ly/3Wmxc6G
$KTRA #KTRA
Congratulations to @GCAResearch & @Kintara_Thera for ringing the NASDAQ closing bell with our #GBMAGILE partners, patients, caregivers, and physicians united to raise awareness of the critical, unmet need for new treatment options for patients with GBM.
John de Groot, MD retweeted
Thank you @Nasdaq for inviting us to ring the closing bell in honor of National Brain Tumor Awareness Month! #GoGrayinMay
.@GCAResearch and partners join us at MarketSite to close the markets to bring awareness to #BrainTumorAwarenessMonth.
The Global Coalition for Adaptive Research, GCAR, is a global research organization that leads GBM AGILE, an innovative clinical trial for patients with glioblastoma or G.B.M. to help champion and expedite the discovery, development and implementation of treatment.
John de Groot, MD retweeted
Thank you to everyone who joined us @Nasdaq today!
@NBTStweets @NFCR @AFCR_org @StacheStrong @BayerPharma @KaziaTx @Kintara_Thera @vigeotx @biohaven Polaris Pharmaceuticals @xelamb, @Sujuan_Ba Patrick Wen, Ingo Mellighoff, @ErikSulman, @J_deGrootMD, Andrew Lassman
John de Groot, MD retweeted
Have you considered participating in a clinical trial? Get tips for navigating the process and overcoming barriers in accessing them during a free webinar. Register: bit.ly/MayWebinar23 #btsm #braintumor
@MDAndersonNews
John de Groot, MD retweeted
Congratulations to our department chair Edward Chang, MD, on receiving @SNS_Neurosurg's Winn Prize! 🎉 He is the 2nd @UCSF neurosurgeon to be honored with this prestigious award recognizing an outstanding commitment to neuroscience research. #SNS2023 #UCSFproud @CNS_Update
ALT Graphic showing a photo of Edward Chang, MD. Text below his photo says: Edward Chang, MD; 2023 H. Richard Winn, MD Prize; The Society of Neurological Surgeons.
John de Groot, MD retweeted
GCAR Associate Clinical Scientist, Emma Viktoria Hyddmark at #AACR23 with the #GBMAGILE clinical trial in progress poster 🧠 #GBM #glioblastoma #clinicaltrial
John de Groot, MD retweeted
Thanks so much @NeurosurgUCSF for being one of sponsors for an inspiring day with @NBTStweets for the Northern California Brain Tumor Walk! We will keep trying to find a cure!! @J_deGrootMD @ManishKAghi @LabRaleigh and so many others!!
An honor to be invited and present at @BTWarsaw. Lots of fantastic science presented and discussed. Thank you prof. Bożena Kamińska-Kaczmarek and her incredible team for everything!
@J_deGrootMD was the Keynote Speaker on the first day at @BTWarsaw ❗️
Hope you’re ready for more lectures today 🥳
Programme: braintumorswarsaw.pl/index.p…
John de Groot, MD retweeted
Happy to see young MDs participating in research reporting conferences 👨🏻⚕️🔁👨🏻🔬 #BTWarsaw22 #science
John de Groot, MD retweeted
Very happy to share our paper in @NatureGenet reporting meningiomas are comprised of 3 DNA methylation groups with distinct outcomes, drivers, and therapeutic vulnerabilities. nature.com/articles/s41588-0…. @LabRaleigh @abrarc @StephenTMagill @chunkybungle @NeurosurgUCSF @UCSFCancer
John de Groot, MD retweeted
Third day of the National Cancer Advisory Board Meetings @theNCI. The Cancer Moonshot 1.0 will be concluding next year and the new Cancer Moonshot 2.0 is focused on the following:
Outstanding collaboration between Dr Weathers, @JenWargoMD and @nadim_ajami on gut microbiome in newly diagnosed GBM. Exciting new data on potential role of the microbiome on response to therapy.
